Clinical Report: Therapeutic Group Interventions for PTSD Symptoms in Veterans
Overview
This report evaluates the efficacy of the Warrior Renew group treatment for PTSD symptoms associated with military sexual trauma (MST) in veterans.
Background
Military sexual trauma (MST) is a prevalent issue among veterans, with significant rates of PTSD and other psychiatric symptoms resulting from such experiences. Current treatments for PTSD, including prolonged exposure and cognitive processing therapy, are not specifically tailored for MST-related symptoms.
Data Highlights
Intervention
Effect Size (Cohen d)
Dropout Rate
Warrior Renew
0.59 to 2.07
Low
Prolonged Exposure
N/A
28.7%
Cognitive Processing Therapy
N/A
34.0%
Key Findings
MST incidence rates are reported at 22% for women and 1% for men in the military.
Approximately 42% of women and 4% to 12.5% of men have experienced MST according to self-report studies.
Warrior Renew demonstrated improvements in PTSD symptoms with medium to large effect sizes.
A longitudinal trial showed sustained improvements in PTSD symptoms 12 months post-treatment.
Dropout rates for traditional PTSD treatments like PE and CPT are higher than those for Warrior Renew.
Clinical Implications
The findings suggest that MST-focused interventions like Warrior Renew may provide more effective treatment options for veterans with PTSD related to military sexual trauma. Clinicians should consider the unique needs of MST survivors when selecting treatment modalities.
Conclusion
The study supports the efficacy of Warrior Renew as a promising group intervention for PTSD symptoms associated with MST, warranting further research and potential integration into standard care practices.
by Amanda E. Wood, Belle A. Zaccari, Travis Y. Hee Wai, My N. Crooker, Miles S. Evanisko, Justin B. Clark, Julia B. Sewell, ShienPei C. Silverman, Sharon J. Dolph, Lori S. Katz